BioPlus Acquisition Corp Valuation

Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. BioPlus Acquisition Corp prevailing Real Value cannot be determined due to lack of data. The current price of BioPlus Acquisition Corp is $0.0. Our model approximates the value of BioPlus Acquisition Corp from analyzing the firm fundamentals such as Return On Asset of -0.0072, shares outstanding of 19.37 M, and Shares Owned By Institutions of 51.31 % as well as examining its technical indicators and probability of bankruptcy.

BioPlus Acquisition Total Value Analysis

BioPlus Acquisition Corp is currently estimated to have valuation of 215.16 M with market capitalization of 208.98 M, debt of 5 M, and cash on hands of 294.69 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the BioPlus Acquisition fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
215.16 M
208.98 M
M
294.69 K

BioPlus Acquisition Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of BioPlus implies not a very effective usage of assets in March.

BioPlus Acquisition Ownership Allocation

Over half of BioPlus Acquisition's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions.

BioPlus Acquisition Profitability Analysis

Net Income was 2 M with profit before overhead, payroll, taxes, and interest of 0.

BioPlus Acquisition Growth Indicators

Investing in growth stocks can be very risky. If the company such as BioPlus Acquisition does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding597.8 M
Quarterly Earnings Growth Y O Y58.614
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in BioPlus Stock

If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing